Clinical investigations support regulatory decisions. Under the MDR, expectations for clinical evidence, documentation, and traceability are clearer, and the margin for interpretation is smaller.
As a medical device CRO, we support pre-market studies and post-market clinical follow-up to generate evidence that withstands scrutiny.
Medical Device Post-Marketing Clinical Follow-Up
Medical device clinical investigation projects are rarely standalone activities. They sit within a broader regulatory, clinical, and quality context.
We typically work with teams responsible for:
This solution applies when clinical data is required to demonstrate conformity, support claims, or maintain market access.
Under the MDR, the challenge is not conducting a study. It is ensuring that the study meaningfully supports the intended regulatory conclusion.
In practice, this depends on:
Clinical investigation work when regulatory intent and clinical execution remain aligned throughout.
As an experienced medical device CRO, we focus on integrating clinical investigation into your overall regulatory strategy.
That includes:
The objective is not just to generate data, but to generate evidence that can be used.
Medical device clinical investigation benefit from clarity early on. We align first on regulatory context, clinical purpose, and documentation requirements. From there, investigation plan is executed with clear ownership and oversight, adapted to the device, its risk profile, and the healthcare environment.
You work with a consistent team that understands both the clinical and regulatory dimensions of your program, reducing the need for reinterpretation later.
For medical devices, the real test of a clinical investigation often comes after execution. Investigation plan design choices, documentation structure, and reporting are aligned from the start so that clinical evidence supports regulatory conclusions without requiring retrospective justification. The emphasis is on traceability, clarity, and consistency across the full clinical investigation file.
Clinical investigation need to fit into existing quality systems and regulatory workflows.
This approach is designed to integrate with how your organization already works, rather than introducing parallel structures. Clinical activities align with your quality management system, internal review processes, and regulatory timelines. That alignment reduces internal friction and avoids unnecessary rework.
When you evaluate clinical investigation partners, the question is not whether a study can be run. It is whether the resulting evidence will stand up beyond the study itself.
“Under the MDR, we quickly realized that having data wasn’t enough. APICES helped us build the evidence package the right way.”
Talk to our expert, Director of Global Clinical Operations, Ana Moreno. If you are preparing your next medical device study or want to sanity-check your program’s setup, the next step is a focused conversation.
No packaged answers. Just context, experience, and a clear view on fit.
